Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG

LONDON - The 2009 Frost & Sullivan European Drug Discovery Product Innovation
Award is presented to Xenometrix AG in recognition of its active role in the
production of single and multiple endpoint cytotoxicity assays.

(Logo: www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )

These test kits, used in the early screening stages of drug discovery,
improve the effectiveness of drug discovery and development through lead
optimisation. One product line - the IN CYTOTOX PAN I kit - enables
researchers to detect 4 main toxicity parameters on a single sample; a feat
unmatched by competing life science organisations.

“The multiple endpoint IN CYTOTOX test kits are able to determine up to
four metabolic parameters from the same cellular sample,” explains Frost &
Sullivan Research Analyst Dr. Laleh Safinia. “The kit eases some of the
bottlenecks in preclinical drug discovery and development and increases the
relevance of correlation of the tests, reduces the overall handling time,
volume of test compounds needed, plastic waste and consequently, the cost.”

The PAN I cytotoxicity kit allows the application of 4 commonly used
cytotoxicity assays sequentially on a cellular sample. Such an approach
enhances the probability of identifying toxic compounds, reduces consumption
of valuable primary cells, uses lower test compounds than with individual
assays and removes inter-assay variability due to differences in cell
composition, cellular activity and cell density.

“Xenometrix offers testing of chemicals for cytotoxic effects using a
range of assays and assay combinations sold as test kits,” states Safinia.
“The cytotoxicity kits are used by major pharmaceutical, chemical and
cosmetic industries, contract service labs as well as authorities analysing
environmental toxicants.”

Xenometrix AG uses either its own cell lines or can accommodate
customers’ own cells. Company personnel are highly experienced in all aspects
of cell culture and have a detailed knowledge of individual assays.
Accordingly, they can optimally meet the testing needs of customers, and can
advise them on the assay(s) and assay conditions.

“Such in-house compound testing expertise enables the company to offer
fast, reliable and customised service according to the needs of the customer
through a fully interactive process,” adds Safinia. “Xenometrix offers
complete customer support free-of-charge with respect to technical or
scientific questions, practical training, as well as rapid customer compound
testing with all assay systems.”

Each year, the Frost & Sullivan Award for Product Innovation is presented
to the company that has demonstrated excellence in new products and
technologies within its industry. The recipient company has shown innovation
by launching a broad line of emerging products and technologies.

Frost & Sullivan Best Practices Awards recognise companies in a variety
of regional and global markets for demonstrating outstanding achievement and
superior performance in areas such as leadership, technological innovation,
customer service, and strategic product development. Industry analysts
compare market participants and measure performance through in-depth
interviews, analysis, and extensive secondary research in order to identify
best practices in the industry.

About Xenometrix AG

Xenometrix produces and distributes today’s most advanced mutagenicity
assays and cytotoxicity screening kits designed to help to reduce test
compound consumption, minimizing hands-on-time, plastic waste, and
consequently lessening costs.

Xenometrix is developing Ames microplate fluctuation testkits and
cytotoxicity screening assays since 1995 with the vision of “excellence in
quality and service.” Xenometrix offers a full customer support free of
charge, and upon demand analytical service of all assay systems with a rapid
turn-around. Please visit: www.xenometrix.ch.

Contact:

Dr. Nicole Weiland, Xenometrix AG, Tel. +41-61-482-14-34,
Fax +41-61-482-20-72
nwj@xenometrix.ch, www.xenometrix.ch

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to
accelerate growth and achieve best in class positions in growth, innovation
and leadership. The company’s Growth Partnership Service provides the CEO and
the CEO’s Growth Team with disciplined research and best practice models to
drive the generation, evaluation and implementation of powerful growth
strategies. Frost & Sullivan leverages over 45 years of experience in
partnering with Global 1000 companies, emerging businesses and the investment
community from 31 offices on six continents. To join our Growth Partnership,
please visit www.frost.com.

Contact:

Ciara Jamie Connolly, Senior Events & Promotions Executive, EMEA,
Best Practices, Frost & Sullivan, ciara.connolly@frost.com,
P: +44-(0)-207-915-7868, F: +44-(0)-207-730-3343,
www.frost.com/

Source: Frost & Sullivan

Ciara Jamie Connolly, Senior Events & Promotions Executive, EMEA, Best Practices of Frost & Sullivan, +44-(0)-207-915-7868, fax, +44-(0)-207-730-3343, ciara.connolly at frost.com; or Dr. Nicole Weiland of Xenometrix AG, +41-61-482-14-34, fax, +41-61-482-20 72, nwj at xenometrix.ch. Photo: https://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO